Frontlight ResearchEarly access
Immune thrombocytopenia (ITP) trials in Bangladesh
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleRole of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
- Where
- Dhaka
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Renata PLC
See details and how to joinNCT06531018